[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$f_07zq4sqk24ydIfOWQymCaoX2wty0-m4rJeBdPKrWpo":8,"$fzB1_yMLzOA8-Ip39cjS93djo8CTNFr9gvpQ50fWNWss":55,"$fjovZdTLozjZmeLJBC9LNXwOnxHtYKncJ-Ir7Gr3yi4E":59},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":54},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":26,"views":27,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":28,"seoTitle":22,"seoKeywords":29,"seoDescription":30,"shelvesTime":31,"version":32,"menus":33,"menuId":35,"type":42,"quality":53,"commentCount":21,"isComment":42},71864,867444,[],"https://ystcdn.venuertc.com/medical/ystApp/1nYSFTBe7EEeXfics4mAqBBpLeJ6MPMd.png","王江芬","山西省人民医院","肿瘤科","主治医师",114,0,"了解浸润性导管癌：识别、诊断与治疗指南","","https://ystcdn.venuertc.com/venue/AI/a6b8eb3c-1730-4aee-8eae-e954e9fe7433.jpg","\u003Cdiv class=\"invasiveca_material_container\">\n  \u003Ch1 id=\"material_title\" class=\"invasiveca_title\">了解浸润性导管癌：识别、诊断与治疗指南\u003C/h1>\n  \n  \u003Cdiv class=\"invasiveca_section invasiveca_background1\">\n    \u003Ch2 class=\"invasiveca_subtitle\">01 认识浸润性导管癌\u003C/h2>\n    \u003Cdiv class=\"invasiveca_content\">\n      \u003Cp>\n        日常生活中，乳腺问题越来越被女性朋友关注，乳腺癌的新闻、体检防癌广告时常出现在身边。其实，在乳腺癌里，“浸润性导管癌”是占比最高的一种。不少女性第一次听到这个名词，都会问：“到底它是怎么回事？”\n      \u003C/p>\n      \u003Cp>\n        简单说，浸润性导管癌（Invasive Ductal Carcinoma, IDC）是一种从乳腺导管起源、可向周围组织扩散的肿瘤。与原位癌相比，浸润性导管癌的细胞有“越界”本事，一旦穿破乳腺导管膜，就可能悄渗入乳腺组织甚至更远地方。它常见于40岁以上女性，但近年也有年轻化的趋势。发现得早，治愈机会大；拖得久，就会更复杂。\n      \u003C/p>\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"invasiveca_section invasiveca_background2\">\n    \u003Ch2 class=\"invasiveca_subtitle\">02 怎么识别浸润性导管癌的症状？\u003C/h2>\n    \u003Cdiv class=\"invasiveca_content\">\n      \u003Cp>\n        浸润性导管癌的症状常并不典型，早期尤其容易“低调”地出现。通常，最早期信号是乳房摸到小硬块，形状不规则、质地较硬，多数不会疼痛。偶尔有些人会觉得乳房皮肤有点“怪”，比如有橘皮样变化，或者乳头变形，但这种情况较少。\n      \u003C/p>\n      \u003Cp>\n        随着癌症进展，症状会变明显。一旦出现乳头异常分泌物（尤其带血）、乳头凹陷、乳房局部皮肤发红或溃烂等持续的变化，就要引起警觉。这时往已经不是早期，需要尽快就医诊治。\n      \u003C/p>\n      \u003Cp class=\"invasiveca_emoji\">🔍 小提示：乳房自检，每月一次，特别是在经期结束后几天左右。任何持续、无法解释的新变化都该认真对待。\u003C/p>\n      \u003Cdiv class=\"invasiveca_case invasiveca_case1\">\n        \u003Cspan class=\"invasiveca_case_tag\">案例启发\u003C/span>\n        \u003Cp>\n          一位43岁女性患者，在洗澡时摸到左乳有个小硬块，并伴有限的恶心、轻微不适，自检无明显疼痛。检查后被确诊为浸润性导管癌，幸好发现比较早。这个例子提示：日常自检真能帮大忙，不要因为“没感觉”就忽略体检。\n        \u003C/p>\n      \u003C/div>\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"invasiveca_section invasiveca_background3\">\n    \u003Ch2 class=\"invasiveca_subtitle\">03 导致浸润性导管癌的关键因素\u003C/h2>\n    \u003Cdiv class=\"invasiveca_content\">\n      \u003Cp>\n        很多人疑惑：为什么有的人容易得乳腺癌？其实，风险高低受多种因素影响。主要分为这几类：\n      \u003C/p>\n      \u003Col class=\"invasiveca_list\">\n        \u003Cli>\n          \u003Cspan class=\"invasiveca_bold\">遗传基因：\u003C/span>家族有乳腺癌史，特别是有BRCA1、BRCA2基因变异的女性，患乳腺癌风险会显著升高。研究显示，这两种基因变异会让罹患概率增加5-10倍。\u003Cspan class=\"invasiveca_emoji\">🧬\u003C/span>（参考：Antoniou et al., 2003, \u003Ci>American Journal of Human Genetics\u003C/i>）\n        \u003C/li>\n        \u003Cli>\n          \u003Cspan class=\"invasiveca_bold\">年龄与激素影响：\u003C/span>40岁以上女性属于高发群体，尤其是50岁以后的女性。此外，年轻时月经初潮早、绝经晚、长期使用激素类药物等都会提高风险。（Mavaddat et al., 2010, \u003Ci>Journal of the National Cancer Institute\u003C/i>）\n        \u003C/li>\n        \u003Cli>\n          \u003Cspan class=\"invasiveca_bold\">生活习惯：\u003C/span>高热量饮食、缺乏运动、肥胖以及长期压力，都可能为异常细胞提供成长空间。不过，这些只是增加几率，并不一定每个人都会得病。\n        \u003C/li>\n      \u003C/ol>\n      \u003Cp>\n        需要分清的是，风险因素只是“外因”，有的人所有风险都中招却依旧健康，也有人没啥不良习惯却偏得病。因此，规律体检很重要。\n      \u003C/p>\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"invasiveca_section invasiveca_background4\">\n    \u003Ch2 class=\"invasiveca_subtitle\">04 常用的检查与确诊流程有哪些？\u003C/h2>\n    \u003Cdiv class=\"invasiveca_content\">\n      \u003Cp>\n        一旦怀疑有浸润性导管癌，医生通常会建议做为数不多但关键的几项检查：\n      \u003C/p>\n      \u003Cul class=\"invasiveca_list\">\n        \u003Cli>\n          \u003Cspan class=\"invasiveca_bold\">乳腺X线（钼靶）或超声：\u003C/span>通过影像，可以看出肿块大小、形态及是否有钙化点，是初筛首选方法。X线更适合40岁以上的女性，年轻女性乳腺较致密则优选超声。\n        \u003C/li>\n        \u003Cli>\n          \u003Cspan class=\"invasiveca_bold\">活组织检查（活检）：\u003C/span>如果影像发现“可疑区域”，下一步就要通过穿刺活检提取一小块组织。病理分析后，才能确诊是不是浸润性导管癌。\n        \u003C/li>\n        \u003Cli>\n          \u003Cspan class=\"invasiveca_bold\">免疫组化检测：\u003C/span>确诊后，医生还会做一系列免疫组化检查，比如ER、PR、HER-2、Ki-67等。这些数据相当于“肿瘤身份证”，用于指导后续治疗方案选择（Duffy et al., 2011, \u003Ci>Cancer Treatment Reviews\u003C/i>）。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cp>\n        检查会让人紧张，尤其是活检操作。不过，绝大多数活检痛感很轻微，且事关关键诊断，因此千万不必拖延或因为害怕而逃避。\n      \u003C/p>\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"invasiveca_section invasiveca_background5\">\n    \u003Ch2 class=\"invasiveca_subtitle\">05 治疗方式和效果期待\u003C/h2>\n    \u003Cdiv class=\"invasiveca_content\">\n      \u003Cp>\n        治疗浸润性导管癌,需要综合多种方案，各有优劣，最终选择离不开专业团队的综合评估。一般来说，主流方式主要有三种：\n      \u003C/p>\n      \u003Col class=\"invasiveca_list\">\n        \u003Cli>\n          \u003Cspan class=\"invasiveca_bold\">手术治疗：\u003C/span>首选方案。根据肿瘤位置、大小和淋巴结情况，医生会建议部分切除或全乳切除。手术可最大限度清除病变组织，为后续治疗“打基础”。\n        \u003C/li>\n        \u003Cli>\n          \u003Cspan class=\"invasiveca_bold\">放疗/化疗：\u003C/span>针对术后残留癌细胞，或病情进展的患者。部分患者术前化疗可缩小肿瘤、提高保乳率。实际用药方案严格根据指南制定，如病例中采用的多西他赛+卡铂，属于标准推荐组合。\n        \u003C/li>\n        \u003Cli>\n          \u003Cspan class=\"invasiveca_bold\">内分泌与靶向治疗：\u003C/span>对ER/PR阳性和HER-2阳性患者，内分泌阻断和靶向药物（如抗HER-2抗体）效果突出。\u003Cspan class=\"invasiveca_emoji\">💊\u003C/span>\n        \u003C/li>\n      \u003C/ol>\n      \u003Cp>\n        治疗效果与肿瘤分期、分型有关。早发现早治疗，5年生存率可达九成以上。即使诊断较晚，科学系统治疗也能极大延长生命、改善生活质量。\n      \u003C/p>\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"invasiveca_section invasiveca_background6\">\n    \u003Ch2 class=\"invasiveca_subtitle\">06 日常生活管理与健康建议\u003C/h2>\n    \u003Cdiv class=\"invasiveca_content\">\n      \u003Cp>\n        治疗只是第一步，日常护理和健康生活方式同样重要。如果想更好地辅助康复、降低复发风险，可以从以下细节着手：\n      \u003C/p>\n      \u003Cul class=\"invasiveca_list\">\n        \u003Cli>\n          \u003Cspan class=\"invasiveca_bold\">均衡饮食：\u003C/span>多摄入富含膳食纤维的新鲜蔬菜（如西兰花、胡萝卜、菠菜）和水果，有助于提升身体的抗病能力。优选低脂乳制品和优质蛋白（如鱼、鸡蛋、豆制品），减少油腻烹饪方式。\n        \u003C/li>\n        \u003Cli>\n          \u003Cspan class=\"invasiveca_bold\">保持规律锻炼：\u003C/span>建议每周进行150分钟中等强度活动，比如快步走、游泳、骑车等。定期锻炼能帮助体重管理和情绪调节。\n        \u003C/li>\n        \u003Cli>\n          \u003Cspan class=\"invasiveca_bold\">心理调适：\u003C/span>癌症诊断常伴随焦虑和压力，适当与家人朋友交流，必要时寻求心理援助，可减轻精神负担。发现情绪持续低落可以主动咨询心理咨询师。\n        \u003C/li>\n        \u003Cli>\n          \u003Cspan class=\"invasiveca_bold\">定期复查：\u003C/span>治疗后建议根据医生建议按时复查，内容包括乳腺影像学检查和肿瘤标志物监测。乳腺自检也很重要，发现异常立即就医。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cp>\n        \u003Cspan class=\"invasiveca_emoji\">🌱\u003C/span> 养成这些习惯不只是防癌，整体健康状况也会随之提升。饮食和运动没有标准模板，每个人可以根据自己的喜好和医生建议做出调整。\n      \u003C/p>\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"invasiveca_conclusion\">\n    \u003Ch2 class=\"invasiveca_subtitle\">小结\u003C/h2>\n    \u003Cdiv class=\"invasiveca_content\">\n      \u003Cp>\n        可以看出，浸润性导管癌并不可怕，关键是要重视乳腺自检和常规筛查，发现疑似情况时及时就医。治疗手段在不断更新，绝大多数患者都能通过规范的治疗实现良好预后。日常生活中，保持健康饮食和适量运动，不光能帮助康复，还对整体健康很有好处。学会自我关爱，遇到问题及时寻求专业帮助，是面对疾病更有效的方式。\n      \u003C/p>\n    \u003C/div>\n  \u003C/div>\n  \n  \u003Cdiv class=\"invasiveca_refbox\">\n    \u003Ch3 class=\"invasiveca_reftitle\">参考文献\u003C/h3>\n    \u003Cul class=\"invasiveca_reflist\">\n      \u003Cli>Antoniou, A. C., et al. (2003). Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies. \u003Ci>American Journal of Human Genetics, 72\u003C/i>(5), 1117-1130.\u003C/li>\n      \u003Cli>Mavaddat, N., Antoniou, A. C., Easton, D. F., & Garcia‐Closas, M. (2010). Genetic susceptibility to breast cancer. \u003Ci>Journal of the National Cancer Institute, 102\u003C/i>(6), 426-441.\u003C/li>\n      \u003Cli>Duffy, M. J., et al. (2011). Biology of breast cancer. \u003Ci>Cancer Treatment Reviews, 37\u003C/i>(1), 1-7.\u003C/li>\n    \u003C/ul>\n  \u003C/div>\n\u003C/div>\n\n\u003Cstyle>\n.invasiveca_material_container {\n  max-width: 800px;\n  margin: 40px auto 60px auto;\n  background: #fc;\n  border-radius: 18px;\n  box-shadow: 0 4px 22px rgba(30,50,70,0.08);\n  font-family: 'Segoe UI', 'PingFang SC', Arial, sans-serif;\n  padding-bottom: 24px;\n}\n.invasiveca_title {\n  font-size: 2.2em;\n  text-align: center;\n  color: #274272;\n  margin-top: 38px;\n  margin-bottom: 32px;\n  line-height: 1.3;\n  letter-spacing: 1px;\n}\n.invasiveca_section {\n  margin: 0 34px 32px 34px;\n  border-radius: 12px;\n  box-shadow: 0 2px 10px rgba(120,170,255,0.03);\n  padding: 32px 26px 24px 26px;\n  position: relative;\n  overflow: hidden;\n}\n.invasiveca_background1 {\n  background: linear-gradient(100deg, #e6f0ff 40%, #ffffff 100%);\n}\n.invasiveca_background2 {\n  background: linear-gradient(100deg, #fdeff6 40%, #fff 100%);\n}\n.invasiveca_background3 {\n  background: linear-gradient(100deg, #f3fff4 40%, #fff 100%);\n}\n.invasiveca_background4 {\n  background: linear-gradient(100deg, #fff9e8 40%, #fff 100%);\n}\n.invasiveca_background5 {\n  background: linear-gradient(100deg, #f4f8ff 40%, #fff 100%);\n}\n.invasiveca_background6 {\n  background: linear-gradient(100deg, #f9feec 40%, #fff 100%);\n}\n.invasiveca_subtitle {\n  font-size: 1.35em;\n  color: #206cc4;\n  border-left: 7px solid #8ac6ff;\n  background-color: rgba(255,255,255,0.58);\n  padding: 7px 0 7px 18px;\n  margin-bottom: 15px;\n  margin-top: 0;\n  font-weight: 600;\n  border-radius: 3px;\n  letter-spacing: .5px;\n}\n.invasiveca_content {\n  font-size: 1.05em;\n  color: #323e4a;\n  line-height: 1.9;\n  margin-bottom: 2px;\n}\n.invasiveca_list {\n  padding-left: 23px;\n  margin-bottom: 14px;\n}\n.invasiveca_bold {\n  font-weight: 600;\n  color: #164085;\n}\n.invasiveca_emoji {\n  font-size: 1.25em;\n  padding-left: 7px;\n  color: #f4900c;\n}\n.invasiveca_case {\n  margin-top: 15px;\n  background: #fff;\n  border-left: 5px solid #f6d0e3;\n  color: #5c2282;\n  padding: 12px 22px;\n  font-size: 1em;\n  border-radius: 7px;\n}\n.invasiveca_case_tag {\n  display: inline-block;\n  font-size: 0.95em;\n  background: #f7e1f4;\n  color: #ae1cbc;\n  border-radius: 8px;\n  padding: 1px 11px;\n  margin-right: 9px;\n  font-weight: 500;\n}\n.invasiveca_conclusion {\n  margin: 0 34px 32px 34px;\n  background: linear-gradient(100deg, #f1faff 40%, #fff 100%);\n  border-radius: 12px;\n  box-shadow: 0 2px 8px rgba(100,180,200,0.06);\n  padding: 26px 22px 14px 22px;\n}\n.invasiveca_refbox {\n  margin: 0 34px 0 34px;\n  background: #f7fbff;\n  border-radius: 11px;\n  padding: 20px 24px;\n}\n.invasiveca_reftitle {\n  font-size: 1.11em;\n  color: #2867ac;\n  margin-top: 0;\n  margin-bottom: 9px;\n  font-weight: 600;\n}\n.invasiveca_reflist {\n  font-size: 0.97em;\n  color: #5a626e;\n  padding-left: 19px;\n  margin: 0;\n  line-height: 1.7;\n}\n@media (max-width: 600px) {\n  .invasiveca_material_container {\n    margin: 12px 2% 24px 2%;\n    padding: 0;\n  }\n  .invasiveca_section, .invasiveca_conclusion, .invasiveca_refbox {\n    margin: 0 4px 18px 4px;\n    padding: 18px 7px 11px 7px;\n  }\n  .invasiveca_title {\n    font-size: 1.55em;\n    margin: 20px 0 16px 0;\n  }\n}\n\u003C/style>","\u003Cdiv class=\"invasiveca_material_container\">\n  \u003Ch1 id=\"material_title\" class=\"invasiveca_title\">了解浸润性",591,"2025-11-11 00:19:32","浸润性导管癌, 乳腺癌, 乳腺检查, 乳房硬块, 自我检测, 女性健康, 癌症治疗, 乳腺疾病","深入了解浸润性导管癌，包括症状识别、诊断流程及治疗方案，帮助40岁以上女性预防和应对乳腺癌，掌握自我检测与健康生活方式。","2025-11-18 14:13:42",2,[34],{"menuId":35,"menuName":36,"parentId":21,"orderNum":32,"path":37,"component":38,"isFrame":39,"isCache":40,"menuType":41,"visible":42,"status":21,"createDept":6,"remark":23,"createTime":43,"children":44,"columnImage":45,"columnLogo":46,"uncheckedLogo":6,"checkedLogo":6,"isHot":42,"isHome":21,"forceLogin":21,"color":47,"seoTitle":48,"seoKeywords":49,"seoDescription":50,"contentNum":6,"promotionalPoster":51,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":52,"routerPath":37,"componentInfo":38},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤,重大疾病",true,{"code":9,"msg":10,"message":6,"data":56,"success":54},{"pageNo":42,"pageSize":57,"result":58,"totalSize":21},10,[],{"code":9,"msg":10,"message":6,"data":60,"success":54},{"authors":61,"appraiseDimensionScoresVos":62},[],[]]